Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Bonnet

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Genetics|December 22, 2004
Evidence for genetic control of adult weight plasticity in the snail Helix aspersaMathieu Ros, Daniel Sorensen, Rasmus Waagepetersen, et al.
Vaccine|May 12, 2009
Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategiesMaría Catalina Pírez, Ignacio Olivera, Hugo Diabarboure, et al.
Melanoma Research|March 14, 2008
Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrateGünther F L Hofbauer, Tobias Baur, Marie-Claude Bonnet, et al.
Vaccine|November 1, 2015
A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccineMitsunobu Miyazu, Hitoshi Kikuchi, Atsuo Hamada, et al.
Drug Development and Industrial Pharmacy|November 4, 2004
Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulationAlain Bayol, Thierry Breul, Patrice Dupin, et al.
Biotechnology and Applied Biochemistry|August 1, 2002
Modification of a reactive cysteine explains differences between rasburicase and Uricozyme, a natural Aspergillus flavus uricaseAlain Bayol, Joël Capdevielle, Pascal Malazzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony- stimulating factor induced a tumor-specific cellular immune responseGustav J Ullenhag, Jan-Erik Frödin, Szilvia Mosolits, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|December 3, 2009
[Effectiveness of inactivated poliomyelitis vaccine for primary vaccination]Chang-Gui Li, Zhi-Fang Ying, Jian-Feng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccineSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Infection and Immunity|October 27, 2004
Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese childrenDo Gia Canh, Feng-ying Kimi Lin, Vu Dinh Thiem, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Genetics|December 22, 2004
Evidence for genetic control of adult weight plasticity in the snail Helix aspersaMathieu Ros, Daniel Sorensen, Rasmus Waagepetersen, et al.
Vaccine|May 12, 2009
Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategiesMaría Catalina Pírez, Ignacio Olivera, Hugo Diabarboure, et al.
Melanoma Research|March 14, 2008
Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrateGünther F L Hofbauer, Tobias Baur, Marie-Claude Bonnet, et al.
Vaccine|November 1, 2015
A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccineMitsunobu Miyazu, Hitoshi Kikuchi, Atsuo Hamada, et al.
Drug Development and Industrial Pharmacy|November 4, 2004
Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulationAlain Bayol, Thierry Breul, Patrice Dupin, et al.
Biotechnology and Applied Biochemistry|August 1, 2002
Modification of a reactive cysteine explains differences between rasburicase and Uricozyme, a natural Aspergillus flavus uricaseAlain Bayol, Joël Capdevielle, Pascal Malazzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony- stimulating factor induced a tumor-specific cellular immune responseGustav J Ullenhag, Jan-Erik Frödin, Szilvia Mosolits, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|December 3, 2009
[Effectiveness of inactivated poliomyelitis vaccine for primary vaccination]Chang-Gui Li, Zhi-Fang Ying, Jian-Feng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccineSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Infection and Immunity|October 27, 2004
Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese childrenDo Gia Canh, Feng-ying Kimi Lin, Vu Dinh Thiem, et al.
Pageof 3